Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Perfluorooctanesulfonate (PFOS) perturbs male rat Sertoli cell blood-testis barrier function by affecting F-actin organization via p-FAK-Tyr(407): an in vitro study.

Endocrinology | 2014

Environmental toxicants such as perfluorooctanesulfonate (PFOS) have been implicated in male reproductive dysfunction, including reduced sperm count and semen quality, in humans. However, the underlying mechanism(s) remains unknown. Herein PFOS at 10-20 μM (∼5-10 μg/mL) was found to be more potent than bisphenol A (100 μM) in perturbing the blood-testis barrier (BTB) function by disrupting the Sertoli cell tight junction-permeability barrier without detectable cytotoxicity. We also delineated the underlying molecular mechanism by which PFOS perturbed Sertoli cell BTB function using an in vitro model that mimics the BTB in vivo. First, PFOS perturbed F-actin organization in Sertoli cells, causing truncation of actin filaments at the BTB. Thus, the actin-based cytoskeleton was no longer capable of supporting the distribution and/or localization of actin-regulatory and adhesion proteins at the cell-cell interface necessary to maintain BTB integrity. Second, PFOS was found to perturb inter-Sertoli cell gap junction (GJ) communication based on a dye-transfer assay by down-regulating the expression of connexin-43, a GJ integral membrane protein. Third, phosphorylated focal adhesion kinase (FAK)-Tyr(407) was found to protect the BTB from the destructive effects of PFOS as shown in a study via an overexpression of an FAK Y407E phosphomimetic mutant. Also, transfection of Sertoli cells with an FAK-specific microRNA, miR-135b, to knock down the expression of phosphorylated FAK-Tyr(407) was found to worsen PFOS-mediated Sertoli cell tight junction disruption. In summary, PFOS-induced BTB disruption is mediated by down-regulating phosphorylated FAK-Tyr(407) and connexin-43, which in turn perturbed F-actin organization and GJ-based intercellular communication, leading to mislocalization of actin-regulatory and adhesion proteins at the BTB.

Pubmed ID: 24169556 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: R01 HD056034
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD029990
  • Agency: NICHD NIH HHS, United States
    Id: U54HD029990
  • Agency: NICHD NIH HHS, United States
    Id: R01HD056304

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Goat Anti-Actin Polyclonal antibody, Unconjugated (antibody)

RRID:AB_630836

This polyclonal targets ACTG1, ACTC1, ACTA1, ACTA2, ACTG2, ACTB

View all literature mentions

Filamin A antibody [FLMN01] - BSA and Azide free (antibody)

RRID:AB_1640513

This monoclonal targets Filamin A antibody [FLMN01] - BSA and Azide free

View all literature mentions

CAR (H-300) (antibody)

RRID:AB_2087557

This polyclonal targets CXADR

View all literature mentions

Palladin antibody (antibody)

RRID:AB_2158782

This polyclonal targets Palladin

View all literature mentions

Anti-FAK, clone 4.47 (antibody)

RRID:AB_2173817

This monoclonal targets FAK

View all literature mentions

Connexin 43 Antibody (antibody)

RRID:AB_2294590

This polyclonal targets Connexin 43

View all literature mentions

N-cadherin Monoclonal Antibody (3B9) (antibody)

RRID:AB_2313779

This monoclonal targets N-cadherin

View all literature mentions

JAM-A (CD321) Polyclonal Antibody (antibody)

RRID:AB_2533241

This unknown targets JAM-A (CD321)

View all literature mentions

Phospho-FAK (Tyr407) Polyclonal Antibody (antibody)

RRID:AB_2533708

This unknown targets Phospho-FAK (Tyr407)

View all literature mentions

Occludin Polyclonal Antibody (antibody)

RRID:AB_2533977

This unknown targets Occludin

View all literature mentions

FAK (phospho Y397) antibody (antibody)

RRID:AB_304640

This polyclonal targets FAK (phospho Y397) antibody

View all literature mentions

Vimentin (V9) (antibody)

RRID:AB_628437

This monoclonal targets Vimentin (V9)

View all literature mentions

bovine anti-mouse IgG-HRP (antibody)

RRID:AB_634824

This polyclonal targets bovine anti-mouse IgG-HRP

View all literature mentions

bovine anti-rabbit IgG-HRP (antibody)

RRID:AB_634837

This polyclonal targets Rabbit IgG

View all literature mentions

N-cadherin (H-63) (antibody)

RRID:AB_647794

This polyclonal targets CDH2

View all literature mentions